Additionally, viral therapies such as the oncolytic adenovirus H101 induce endothelial pyroptosis via caspase-1/GSDMD activation, synergizing with anti-PD-L1 therapy to suppress tumor growth (208). Here, GSDMD is linked to neoplasm.